Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pediatric Hematology & Oncology Physician in Oak Lawn, IL
NPI: 1063406825Primary Practice Location
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
4440 W 95th St, Oak Lawn, IL
Primary Employer
Advocate Medical Group
advocatehealth.com
HQ Phone
Get M.D. Rebecca's Phone Numberphone_androidMobile
Get M.D. Rebecca's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
IL State Medical License
2004 - 2026
American Board of Pediatrics
Pediatrics
American Board of Pediatrics
Pediatric Hematology-Oncology
Johns Hopkins University
Fellowship • Pediatric Hematology/Oncology
2006 - 2009
McGaw Medical Center of Northwestern University
Residency • Pediatrics
2002 - 2005
University Of Louisville School Of Medicine
louisville.edu
Medical School
Until 2002
Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.
Authors: Marta Batus, Paul Kent
Publication Date: 2016-03-27
Authors: Christopher Kuo, Karen Fernandez, Marta Batus, Paul Kent
Journal: Pediatr Blood Cancer
Publication Date: 2016-11-05
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Tyrosine Kinase Inhibitor, OTHER: Drug Withdrawn
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, RADIATION: External Beam Radiation Therapy, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, DRUG: Cisplatin, PROCEDURE: Therapeutic Conventional Surgery, DRUG: Busulfan, DRUG: Topotecan Hydrochloride, DRUG: Cyclophosphamide, DRUG: Isotretinoin, DRUG: Vincristine Sulfate, PROCEDURE: Computed Tomography, PROCEDURE: Multigated Acquisition Scan, BIOLOGICAL: Dinutuximab, PROCEDURE: Echocardiography, BIOLOGICAL: Sargramostim, PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation, DRUG: Thiotepa, RADIATION: Iobenguane I-131, DRUG: Doxorubicin Hydrochloride, DRUG: Melphalan Hydrochloride, PROCEDURE: Bone Marrow Aspiration and Biopsy, RADIATION: Iobenguane I-123, DRUG: Etoposide Phosphate, DRUG: Lorlatinib, DRUG: Dexrazoxane Hydrochloride
Lead Sponsor: Children's Oncology Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Laboratory Biomarker Analysis, DRUG: Cisplatin, RADIATION: Radiation Therapy, DRUG: Cyclophosphamide, DRUG: Vincristine Sulfate, DRUG: Lomustine, DRUG: Vincristine
